A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
<br/><strong>Background: </strong>Cryptococcal meningitis is a leading cause of death in HIV-infected patients. International treatment guidelines recommend induction therapy with amphotericin B and flucytosine. This antifungal combination is most effective, but unfortunately flucy...
| Autors principals: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
Wellcome Trust
2019
|